EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hypertensive Heart Disease: A Narrative Review Series—Part 1: Pathophysiology and Microstructural Changes

Valeriya Nemtsova iD, Annina S Vischer iD, Thilo Burkard iD

Journal of Clinical Medicine · 30.03.2023 · 12 (7) · 2606

DOI: 10.3390/jcm12072606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.03.2023. Verfasst von Valeriya Nemtsova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Outpatient Department and Hypertension Clinic, ESH Hypertension Centre of Excellence, University Hospital Basel, 4031 Basel, Switzerland. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sustained hypertension causes structural, functional, and neurohumoral abnormalities in the heart, a disease commonly termed hypertensive heart disease (HHD). Modern concepts of HHD, including processes of remodeling leading to the development of various LVH patterns, HF patterns accompanied by micro- and macrovasculopathies, and heart rhythm and conduction disturbances, are missing in the available definitions, despite copious studies being devoted to the roles of myocardial and vascular fibrosis, and neurohumoral and sympathetic regulation, in HHD development and progression. No comprehensive and generally accepted universal definition and classification of HHD is available to date, implementing diagnostic criteria that incorporate all the possible changes and adaptions to the heart. The aim of this review series is to summarize the relevant literature and data, leading to a proposal of a definition and classification of HHD. This first article reviews the processes of initial myocardial remodeling, and myocardial and vascular fibrosis, occurring in HHD. We discuss important pathophysiological and microstructural changes, the different patterns of fibrosis, and the biomarkers and imaging used to detect fibrosis in HHD. Furthermore, we review the possible methods of targeting myocardial fibrosis in HHD, and highlight areas for further research.

Schlagwörter

Stichwörter der Autor:innen

anti-fibrotic therapiescirculating biomarkershypertensive heart diseaseimagingmyocardial fibrosismyocardial remodelingvascular fibrosis

Autor:innen und Institutionen

  • Medical Outpatient Department and Hypertension Clinic, ESH Hypertension Centre of Excellence, University Hospital Basel, 4031 Basel, Switzerland.
  • Internal Diseases and Family Medicine Department, Educational and Scientific Medical Institute, National Technical University "Kharkiv Polytechnic Institute", 61002 Kharkiv, Ukraine.
  • Department of Cardiology, University Hospital Basel, 4031 Basel, Switzerland.

ORCID-Profile: Valeriya Nemtsova, Annina S Vischer, Thilo Burkard

Zitieren

APA

Nemtsova, V., Vischer, A. S., & Burkard, T. (2023). Hypertensive Heart Disease: A Narrative Review Series—Part 1: Pathophysiology and Microstructural Changes. Journal of Clinical Medicine, 12(7), 2606. https://doi.org/10.3390/jcm12072606

Vancouver

Nemtsova V, Vischer AS, Burkard T. Hypertensive Heart Disease: A Narrative Review Series—Part 1: Pathophysiology and Microstructural Changes. Journal of Clinical Medicine. 2023;12(7):2606. doi:10.3390/jcm12072606

BibTeX
@article{Nemtsova2023,
  author = {Nemtsova, Valeriya and Vischer, Annina S and Burkard, Thilo},
  title = {Hypertensive Heart Disease: A Narrative Review Series—Part 1: Pathophysiology and Microstructural Changes},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {2606},
  doi = {10.3390/jcm12072606}
}
Kostenlos starten →